HBF has taken a 10 per cent stake in ASX-listed dentistry outfit Pacific Smiles Group, following a 10-year partnership agreement struck between the two in 2020.
The Fair Work Commission has ruled against a COVID vaccination mandate applying to coal mine workers in NSW but the ruling is unlikely to have a big impact in Western Australia.
APM is acquiring physiotherapy and home care business Lifecare for $68 million, a move the newly-listed company says will expand its allied health offering and national footprint.
GenesisCare and Icon Cancer Centre have been selected by the WA government to provide oncology services in Perth's greater metropolitan region, under a shared contract worth $21 million.
Local medtech Artrya has listed on the stock exchange, having earlier raised $40 million through an IPO to help commercialise its cardiac imaging software.
Adam Blumenthal has stood aside as chair of Creso Pharma following notice of an ASIC investigation concerning common directorships between the company and its corporate adviser.
The looming vaccination deadline for some of the state’s most critical industries will not exacerbate current labour shortages, Premier Mark McGowan claims.
Shares in Perth-based medicinal cannabis aspirant Emyria were up as much as 21 per cent after the business revealed a $5 million backing from Andrew Forrest’s investment business, Tattarang.
Big Start Capital, headed by the son of Attorney General John Quigley, is suing the state government for damages for allegedly breaching a personal protective equipment supply deal.
The Catholic health care provider moved from the red into the black over the financial year, delivering a $27.1 million surplus from an $8.7 million deficit.
International arrivals to Western Australia will double to 530 per week from next Saturday, as the state reaches a 70 per cent double dose COVID-19 vaccination rate.
Wesfarmers will make a foray into the health and beauty sector after winning the takeover battle with Sigma Healthcare for Priceline owner Australian Pharmaceutical Industries.
Sigma Healthcare has withdrawn efforts to merge with Priceline owner Australian Pharmaceutical Industries leaving Wesfarmers to push ahead with a takeover.
